Ads
related to: Acute Myeloid Leukemia- Side Effects & Safety
Learn About Possible Side Effects
You May Experience During Treatment
- Understanding Ph+ CML-CP
Patients With The T315I Mutation,
Learn About A Treatment Option.
- Treatment Challenges
Patients, Learn About Setting
Goals & Reaching Milestones.
- Ph+ CML-CP Treatment
Visit The Patient Website To
Learn More About This Treatment.
- Side Effects & Safety
Search results
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoLive from ASCO 2024 | Ascentage Pharma Releases Updated Data Showing Promising Efficacy and Safety of Lisaftoclax in Patients with WM PR Newswire SUZHOU, China, and ROCKVILLE, Md., June 4, 2024 ...
ComboMATCH Precision Medicine Cancer Trials
National Cancer Institute· 4 days agoComboMATCH (Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice) is a group of precision medicine cancer clinical trials,...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks· 1 day agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
Celularity Inc. (NASDAQ:CELU) Sees Large Growth in Short Interest
ETF DAILY NEWS· 4 days agoCelularity Inc. (NASDAQ:CELU – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 627,100 shares, a growth of ...
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under...
Digital Journal· 4 days ago...The Company has two clinical-stage oral kinase inhibitors under development for hematologic malignancies: tuspetinib (TUS), an oral, kinase inhibitor that has demonstrated activity as a monotherapy and in combination therapy in patients with relapsed or refractory acute myeloid leukemia (AML) and...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 6 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoLive from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC PR Newswire SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 SUZHOU, China ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoLive from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3% PR Newswire SUZHOU, China and ROCKVILLE, Md., June 4, 2024 SUZHOU, China ...
Jerry Zezima: The Big Climb
The Sacramento Bee· 5 days agoAs a geezer who can barely make it up the dozen steps in my house without getting winded, I never th...
St. Augustine Record Obituaries in Saint Augustine, FL | St. Augustine Record
The St. Augustine Record· 6 days agoMary Lee (Messinese) Weeks passed away peacefully on May 14, 2024, surrounded by family and friends in the Palm Valley home her husband built with love. Mary Lee married her high school sweetheart ...
Ads
related to: Acute Myeloid Leukemia